WallStSmart

Amazon.com Inc (AMZN)vsMEDIFAST INC (MED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amazon.com Inc generates 185734% more annual revenue ($716.92B vs $385.79M). AMZN leads profitability with a 10.8% profit margin vs -4.8%. MED appears more attractively valued with a PEG of 0.97. AMZN earns a higher WallStSmart Score of 59/100 (C).

AMZN

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 3.3Quality: 6.0
Piotroski: 3/9Altman Z: 2.33

MED

Hold

45

out of 100

Grade: D

Growth: 2.0Profit: 2.0Value: 6.0Quality: 6.0
Piotroski: 2/9Altman Z: 5.46
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMZNSignificantly Overvalued (-66.2%)

Margin of Safety

-66.2%

Fair Value

$159.49

Current Price

$265.06

$105.57 premium

UndervaluedFair: $159.49Overvalued

Intrinsic value data unavailable for MED.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMZN3 strengths · Avg: 9.7/10
Market CapQuality
$2.85T10/10

Mega-cap, among the largest globally

Free Cash FlowQuality
$14.94B10/10

Generating 14.9B in free cash flow

Return on EquityProfitability
22.3%9/10

Every $100 of equity generates 22 in profit

MED3 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
5.4610/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.978/10

Growing faster than its price suggests

Areas to Watch

AMZN3 concerns · Avg: 3.7/10
PEG RatioValuation
1.904/10

Expensive relative to growth rate

P/E RatioValuation
31.7x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MED4 concerns · Avg: 2.5/10
Market CapQuality
$118.70M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-9.1%2/10

ROE of -9.1% — below average capital efficiency

Revenue GrowthGrowth
-36.9%2/10

Revenue declined 36.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMZN

The strongest argument for AMZN centers on Market Cap, Free Cash Flow, Return on Equity. Revenue growth of 13.6% demonstrates continued momentum.

Bull Case : MED

The strongest argument for MED centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bear Case : AMZN

The primary concerns for AMZN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Bear Case : MED

The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

AMZN profiles as a value stock while MED is a turnaround play — different risk/reward profiles.

AMZN carries more volatility with a beta of 1.38 — expect wider price swings.

AMZN is growing revenue faster at 13.6% — sustainability is the question.

AMZN generates stronger free cash flow (14.9B), providing more financial flexibility.

Bottom Line

AMZN scores higher overall (59/100 vs 45/100) and 13.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amazon.com Inc

CONSUMER CYCLICAL · INTERNET RETAIL · USA

Amazon.com, Inc. is an American multinational technology company which focuses on e-commerce, cloud computing, digital streaming, and artificial intelligence. It is one of the Big Five companies in the U.S. information technology industry, along with Google, Apple, Microsoft, and Facebook. The company has been referred to as one of the most influential economic and cultural forces in the world, as well as the world's most valuable brand.

Visit Website →

MEDIFAST INC

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.

Visit Website →

Want to dig deeper into these stocks?